Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2025-12-26 @ 3:22 AM
Study NCT ID:
NCT01628692
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2012-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-25
First Submit QC Date:
None
Study First Post Date:
2012-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-13
Results First Submit QC Date:
None
Results First Post Date:
2015-11-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-10
Last Update Post Date:
2017-02-23
Last Update Post Date Type:
ACTUAL